NexGel, Inc. (NASDAQ:NXGL – Free Report)’s stock is set to reverse split on the morning of Monday, October 12th. The 1-20 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, October 11th.
NexGel Stock Down 15.3%
NASDAQ NXGL traded down $0.03 during trading on Thursday, reaching $0.15. 1,312,856 shares of the company’s stock were exchanged, compared to its average volume of 501,067. NexGel has a fifty-two week low of $0.15 and a fifty-two week high of $2.89. The firm has a market capitalization of $1.46 million, a PE ratio of -0.21 and a beta of 0.82. The company has a current ratio of 0.43, a quick ratio of 0.27 and a debt-to-equity ratio of 0.68. The company’s fifty day simple moving average is $0.31 and its 200-day simple moving average is $0.48.
NexGel (NASDAQ:NXGL – Get Free Report) last released its earnings results on Friday, August 14th. The company reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.28). The business had revenue of $3.69 million for the quarter, compared to analysts’ expectations of $4.32 million. NexGel had a negative net margin of 51.26% and a negative return on equity of 121.18%. Sell-side analysts predict that NexGel will post -0.94 EPS for the current year.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Analysis on NexGel
Institutional Trading of NexGel
An institutional investor recently bought a new position in NexGel stock. Empery Asset Management LP purchased a new position in shares of NexGel, Inc. (NASDAQ:NXGL – Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 90,000 shares of the company’s stock, valued at approximately $3,474,000. Empery Asset Management LP owned approximately 0.98% of NexGel as of its most recent filing with the SEC. 2.21% of the stock is currently owned by hedge funds and other institutional investors.
NexGel Company Profile
NexGel, Inc develops and manufactures high-water-content, electron-beam-crosslinked aqueous polymer hydrogels. Its products are designed to provide electrical conductivity, moisture retention, cushioning, and cooling for a range of medical, consumer, and industrial applications.
The company’s hydrogel products are used in medical electrodes for applications such as electrocardiography, neuromuscular stimulation, and defibrillation, as well as in ultrasound procedures. NexGel also supplies nonconductive hydrogels for wound care, burn care, scar treatment, and cosmetic products, along with specialized formulations for veterinary and other commercial uses.
Based in Langhorne, Pennsylvania, NexGel serves customers through business-to-business relationships with medical-device manufacturers and other product companies.
See Also
- Five stocks we like better than NexGel
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for NexGel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexGel and related companies with MarketBeat.com's FREE daily email newsletter.
